+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Breast Cancer Therapeutics Market by Therapy, Stage of Cancer, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011428
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Breast Cancer Therapeutics Market grew from USD 32.90 billion in 2023 to USD 35.55 billion in 2024. It is expected to continue growing at a CAGR of 8.29%, reaching USD 57.49 billion by 2030.

The scope and definition of the breast cancer therapeutics market encompass a range of treatments aimed at managing and combatting breast cancer, including chemotherapy, hormonal therapy, targeted therapy, and immunotherapy. This market's necessity is underscored by the global prevalence of breast cancer, making it a critical area for medical and pharmaceutical advancement. The application of breast cancer therapeutics spans various stages of cancer treatment, from early detection interventions to advanced metastatic conditions, and end-use primarily involves hospitals, cancer therapy centers, and research laboratories. Key growth factors include heightened cancer awareness, increasing government initiatives for cancer treatment, advancements in precision medicine, and a robust pipeline of new drugs pending regulatory approval. The latest opportunities lie in personalized medicine, where innovations like genomic profiling can tailor therapies to individual genetic profiles, and the rising use of AI in early detection and treatment monitoring. To capitalize on these opportunities, organizations can invest in technological collaborations and expand research into novel biomarkers for early diagnosis. However, market growth faces challenges such as high treatment costs, the risk of severe side effects, and stringent regulatory approvals that may hamper the swift adoption of new treatments. Limitations also arise from variances in healthcare infrastructure across regions, particularly in developing economies. Areas ripe for innovation include research into less invasive treatment methods, reducing drug resistance, and developing therapeutics with improved efficacy and reduced side effects. The market is dynamic, characterized by intense competition and rapid technological evolution, necessitating continual adaptation and strategic alliances. Businesses focusing on sustainable innovation, patient accessibility, and comprehensive care solutions are likely to thrive, given the market's progressive nature and the urgent societal need for effective breast cancer treatments.

Understanding Market Dynamics in the Breast Cancer Therapeutics Market

The Breast Cancer Therapeutics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Widely occurring cancer cases across the world
    • Adoption of breast cancer therapeutics for preventive care and early treatment
    • Initiation of breast cancer awareness and screening programmes by government authorities
  • Market Restraints
    • High cost of therapies
  • Market Opportunities
    • R&D initiatives for the development of pharmaceuticals for cancer treatment
    • Favorable insurance and reimbursement policies
  • Market Challenges
    • Adverse effect of chemotherapy on patient’s health

Exploring Porter’s Five Forces for the Breast Cancer Therapeutics Market

Porter’s Five Forces framework further strengthens the insights of the Breast Cancer Therapeutics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Breast Cancer Therapeutics Market

External macro-environmental factors deeply influence the performance of the Breast Cancer Therapeutics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Breast Cancer Therapeutics Market

The Breast Cancer Therapeutics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Breast Cancer Therapeutics Market

The Breast Cancer Therapeutics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Breast Cancer Therapeutics Market

The Breast Cancer Therapeutics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Cancer Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., AstraZeneca plc, Baxter International Inc., Boston Scientific Corporation, Bristol-Myers Squibb Company, Celldex Therapeutics by Avant Immunotherapeutics, Inc., Clovis Oncology, Inc., Daiichi Sankyo Co., Ltd., Eisai Co. Ltd., Eli Lilly and Company, Exelixis Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Hikma Pharmaceuticals plc, Janssen Pharmaceuticals, Inc. by Johnson & Johnson Services, Inc., Macrogenics, Inc., Merck & Co., Inc., NanoString Technologies, Inc., Novartis AG, PerkinElmer, Inc., Pfizer Inc., Puma Biotechnology, Inc., Sanofi S.A., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Breast Cancer Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Therapy
    • Chemotherapy
    • Hormonal Therapy
    • Immunotherapy
    • Targeted Therapy
  • Stage of Cancer
    • Recurrent Breast Cancer
    • Stage 0
    • Stage IV
    • Stages I-III
  • Distribution Channel
    • Offline
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Widely occurring cancer cases across the world
5.1.1.2. Adoption of breast cancer therapeutics for preventive care and early treatment
5.1.1.3. Initiation of breast cancer awareness and screening programmes by government authorities
5.1.2. Restraints
5.1.2.1. High cost of therapies
5.1.3. Opportunities
5.1.3.1. R&D initiatives for the development of pharmaceuticals for cancer treatment
5.1.3.2. Favorable insurance and reimbursement policies
5.1.4. Challenges
5.1.4.1. Adverse effect of chemotherapy on patient’s health
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Breast Cancer Therapeutics Market, by Therapy
6.1. Introduction
6.2. Chemotherapy
6.3. Hormonal Therapy
6.4. Immunotherapy
6.5. Targeted Therapy
7. Breast Cancer Therapeutics Market, by Stage of Cancer
7.1. Introduction
7.2. Recurrent Breast Cancer
7.3. Stage 0
7.4. Stage IV
7.5. Stages I-III
8. Breast Cancer Therapeutics Market, by Distribution Channel
8.1. Introduction
8.2. Offline
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies & Drug Stores
8.3. Online
9. Americas Breast Cancer Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Breast Cancer Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Breast Cancer Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BREAST CANCER THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. BREAST CANCER THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BREAST CANCER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BREAST CANCER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BREAST CANCER THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BREAST CANCER THERAPEUTICS MARKET DYNAMICS
TABLE 7. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY RECURRENT BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE 0, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGES I-III, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST CANCER THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 36. CANADA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 37. CANADA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 38. CANADA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. CANADA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 41. MEXICO BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 58. CHINA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 59. CHINA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 60. CHINA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CHINA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 62. INDIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 63. INDIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 64. INDIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. INDIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 71. JAPAN BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 72. JAPAN BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. JAPAN BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 95. THAILAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 96. THAILAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. THAILAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 109. DENMARK BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. DENMARK BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 112. EGYPT BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 113. EGYPT BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. EGYPT BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 116. FINLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 117. FINLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FINLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 120. FRANCE BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FRANCE BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 124. GERMANY BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 125. GERMANY BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 131. ITALY BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 132. ITALY BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 133. ITALY BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 144. NORWAY BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 145. NORWAY BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. NORWAY BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 147. POLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 148. POLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 149. POLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. POLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 151. QATAR BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 152. QATAR BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 153. QATAR BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. QATAR BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 168. SPAIN BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 169. SPAIN BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SPAIN BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 180. TURKEY BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 181. TURKEY BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. TURKEY BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BREAST CANCER THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM BREAST CANCER THERAPEUTICS MARKET SIZE, BY STAGE OF CANCER, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BREAST CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM BREAST CANCER THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 191. BREAST CANCER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. BREAST CANCER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Breast Cancer Therapeutics market, which are profiled in this report, include:
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Celldex Therapeutics by Avant Immunotherapeutics, Inc.
  • Clovis Oncology, Inc.
  • Daiichi Sankyo Co., Ltd.
  • Eisai Co. Ltd.
  • Eli Lilly and Company
  • Exelixis Inc.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals plc
  • Janssen Pharmaceuticals, Inc. by Johnson & Johnson Services, Inc.
  • Macrogenics, Inc.
  • Merck & Co., Inc.
  • NanoString Technologies, Inc.
  • Novartis AG
  • PerkinElmer, Inc.
  • Pfizer Inc.
  • Puma Biotechnology, Inc.
  • Sanofi S.A.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information